HEADER CONTRACTILE PROTEIN 26-APR-01 1IJJ TITLE THE X-RAY CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN RABBIT SKELETAL TITLE 2 MUSCLE ACTIN AND LATRUNCULIN A AT 2.85 A RESOLUTION COMPND MOL_ID: 1; COMPND 2 MOLECULE: ACTIN, ALPHA SKELETAL MUSCLE; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: ALPHA-ACTIN 1; ACTIN ALPHA, SKELETAL MUSCLE; ALPHA-SKELETAL COMPND 5 ACTIN SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: ORYCTOLAGUS CUNICULUS; SOURCE 3 ORGANISM_COMMON: RABBIT; SOURCE 4 ORGANISM_TAXID: 9986; SOURCE 5 TISSUE: MUSCLE KEYWDS ACTIN, LATRUNCULIN, CYTOSKELETON, CONTRACTILE PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR S.M.VOROBIEV,M.R.BUBB,S.C.ALMO REVDAT 5 16-AUG-23 1IJJ 1 REMARK LINK REVDAT 4 24-FEB-09 1IJJ 1 VERSN REVDAT 3 22-MAR-05 1IJJ 1 HELIX SHEET REVDAT 2 27-SEP-02 1IJJ 1 JRNL REVDAT 1 15-APR-02 1IJJ 0 JRNL AUTH M.R.BUBB,L.GOVINDASAMY,E.G.YARMOLA,S.M.VOROBIEV,S.C.ALMO, JRNL AUTH 2 T.SOMASUNDARAM,M.S.CHAPMAN,M.AGBANDJE-MCKENNA,R.MCKENNA JRNL TITL POLYLYSINE INDUCES AN ANTIPARALLEL ACTIN DIMER THAT JRNL TITL 2 NUCLEATES FILAMENT ASSEMBLY: CRYSTAL STRUCTURE AT 3.5-A JRNL TITL 3 RESOLUTION JRNL REF J.BIOL.CHEM. V. 277 20999 2002 JRNL REFN ISSN 0021-9258 JRNL PMID 11932258 JRNL DOI 10.1074/JBC.M201371200 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH E.G.YARMOLA,T.SOMASUNDARAM,T.A.BORING,I.SPECTOR,M.R.BUBB REMARK 1 TITL ACTIN-LATRUNCULIN A STRUCTURE AND FUNCTION. DIFFERENTIAL REMARK 1 TITL 2 MODULATION OF ACTIN-BINDING PROTEIN FUNCTION BY LATRUNCULIN REMARK 1 TITL 3 A REMARK 1 REF J.BIOL.CHEM. V. 275 28120 2000 REMARK 1 REFN ISSN 0021-9258 REMARK 1 REFERENCE 2 REMARK 1 AUTH W.M.MORTON,K.R.AYSCOUGH,P.J.MCLAUGHLIN REMARK 1 TITL LATRUNCULIN ALTERS THE ACTIN-MONOMER SUBUNIT INTERFACE TO REMARK 1 TITL 2 PREVENT POLYMERIZATION REMARK 1 REF NAT.CELL BIOL. V. 2 376 2000 REMARK 1 REFN ISSN 1465-7392 REMARK 1 DOI 10.1038/35014075 REMARK 2 REMARK 2 RESOLUTION. 2.85 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.0 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.85 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 15.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 2.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 96.9 REMARK 3 NUMBER OF REFLECTIONS : 29269 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.233 REMARK 3 FREE R VALUE : 0.309 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1166 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5496 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 122 REMARK 3 SOLVENT ATOMS : 56 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.61000 REMARK 3 B22 (A**2) : 1.21000 REMARK 3 B33 (A**2) : 0.40000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.48 REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.017 REMARK 3 BOND ANGLES (DEGREES) : NULL REMARK 3 DIHEDRAL ANGLES (DEGREES) : 25.40 REMARK 3 IMPROPER ANGLES (DEGREES) : 1.220 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1IJJ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 30-APR-01. REMARK 100 THE DEPOSITION ID IS D_1000013335. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.8 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : NSLS REMARK 200 BEAMLINE : X9B REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.984 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : NULL REMARK 200 DETECTOR MANUFACTURER : NULL REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 29997 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.850 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.7 REMARK 200 DATA REDUNDANCY : 4.000 REMARK 200 R MERGE (I) : 0.04900 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.85 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.95 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.3 REMARK 200 DATA REDUNDANCY IN SHELL : 3.80 REMARK 200 R MERGE FOR SHELL (I) : 0.52700 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PDB ENTRY 1YAG REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 67.46 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.78 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: AMMONIUM SULFATE, MAGNESIUM CHLORIDE, REMARK 280 PH 6.8, VAPOR DIFFUSION, HANGING DROP AT 298 K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 50.15200 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 62.10900 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 51.09150 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 62.10900 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 50.15200 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 51.09150 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A -1 REMARK 465 CYS A 0 REMARK 465 ASP A 1 REMARK 465 GLU A 2 REMARK 465 ASP A 3 REMARK 465 GLU A 4 REMARK 465 VAL A 43 REMARK 465 MET A 44 REMARK 465 VAL A 45 REMARK 465 GLY A 46 REMARK 465 MET A 47 REMARK 465 GLY A 48 REMARK 465 GLN A 49 REMARK 465 PHE A 375 REMARK 465 MET B 399 REMARK 465 CYS B 400 REMARK 465 ASP B 401 REMARK 465 GLU B 402 REMARK 465 ASP B 403 REMARK 465 PHE B 775 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 THR A 5 OG1 CG2 REMARK 470 HIS A 40 CG ND1 CD2 CE1 NE2 REMARK 470 GLN A 41 CG CD OE1 NE2 REMARK 470 LYS A 50 CG CD CE NZ REMARK 470 TYR A 53 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 GLU A 57 CG CD OE1 OE2 REMARK 470 ASP A 80 OD1 OD2 REMARK 470 LYS A 84 CG CD CE NZ REMARK 470 ARG A 95 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 100 CG CD OE1 OE2 REMARK 470 LYS A 113 CG CD CE NZ REMARK 470 GLU A 167 CG CD OE1 OE2 REMARK 470 LEU A 193 CG CD1 CD2 REMARK 470 THR A 194 OG1 CG2 REMARK 470 GLU A 195 CG CD OE1 OE2 REMARK 470 GLU A 205 CG CD OE1 OE2 REMARK 470 ASN A 225 CG OD1 ND2 REMARK 470 THR A 229 OG1 CG2 REMARK 470 GLU A 237 CG CD OE1 OE2 REMARK 470 LYS A 238 CG CD CE NZ REMARK 470 GLU A 241 CG CD OE1 OE2 REMARK 470 LEU A 242 CG CD1 CD2 REMARK 470 ASP A 244 CG OD1 OD2 REMARK 470 GLU A 253 CG CD OE1 OE2 REMARK 470 ARG A 254 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 256 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 291 CG CD CE NZ REMARK 470 LYS A 315 CG CD CE NZ REMARK 470 LYS A 328 CG CD CE NZ REMARK 470 LYS A 336 CG CD CE NZ REMARK 470 GLN A 353 CG CD OE1 NE2 REMARK 470 LYS A 359 CG CD CE NZ REMARK 470 GLU B 404 CG CD OE1 OE2 REMARK 470 THR B 406 OG1 CG2 REMARK 470 GLN B 441 CG CD OE1 NE2 REMARK 470 VAL B 445 CG1 CG2 REMARK 470 GLN B 449 CG CD OE1 NE2 REMARK 470 LYS B 450 CG CD CE NZ REMARK 470 GLU B 457 CG CD OE1 OE2 REMARK 470 ARG B 462 CD NE CZ NH1 NH2 REMARK 470 ARG B 495 CG CD NE CZ NH1 NH2 REMARK 470 GLU B 500 CG CD OE1 OE2 REMARK 470 LYS B 518 CG CD CE NZ REMARK 470 GLU B 567 CG CD OE1 OE2 REMARK 470 THR B 594 OG1 CG2 REMARK 470 GLU B 605 CG CD OE1 OE2 REMARK 470 LYS B 613 CG CD CE NZ REMARK 470 LYS B 615 CD CE NZ REMARK 470 SER B 632 OG REMARK 470 LEU B 636 CG CD1 CD2 REMARK 470 GLU B 637 CG CD OE1 OE2 REMARK 470 GLU B 641 CG CD OE1 OE2 REMARK 470 GLU B 653 CG CD OE1 OE2 REMARK 470 ARG B 656 CG CD NE CZ NH1 NH2 REMARK 470 GLU B 670 CG CD OE1 OE2 REMARK 470 LYS B 691 CG CD CE NZ REMARK 470 LYS B 715 CG CD CE NZ REMARK 470 LYS B 736 CG CD CE NZ REMARK 470 GLN B 753 CD OE1 NE2 REMARK 470 LYS B 759 CG CD CE NZ REMARK 470 GLU B 764 CG CD OE1 OE2 REMARK 470 LYS B 773 CG CD CE NZ REMARK 470 CYS B 774 SG REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O THR B 704 NH1 ARG B 735 2.09 REMARK 500 O THR A 148 N GLY A 168 2.11 REMARK 500 OG1 THR A 149 N GLU A 167 2.13 REMARK 500 O LEU B 542 OG SER B 545 2.16 REMARK 500 O MET B 683 N CYS B 685 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 CYS B 774 C CYS B 774 O -0.157 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 LEU A 171 CA - CB - CG ANGL. DEV. = -21.8 DEGREES REMARK 500 CYS A 374 CA - CB - SG ANGL. DEV. = 7.1 DEGREES REMARK 500 LEU B 571 CA - CB - CG ANGL. DEV. = -18.0 DEGREES REMARK 500 CYS B 774 CA - C - O ANGL. DEV. = 18.5 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA A 22 108.32 -49.88 REMARK 500 VAL A 30 86.78 -163.33 REMARK 500 SER A 33 52.14 -100.41 REMARK 500 PRO A 38 -153.91 -53.56 REMARK 500 HIS A 40 -158.60 -167.11 REMARK 500 TYR A 53 105.21 172.51 REMARK 500 PHE A 90 -93.76 -55.51 REMARK 500 TYR A 91 -17.66 -43.12 REMARK 500 ARG A 95 70.31 53.68 REMARK 500 ASN A 115 -16.40 -46.01 REMARK 500 ILE A 122 -74.61 -40.41 REMARK 500 MET A 123 -58.02 -29.83 REMARK 500 PHE A 124 -80.96 -63.46 REMARK 500 ALA A 144 24.65 -77.22 REMARK 500 SER A 145 11.66 -143.36 REMARK 500 ARG A 147 140.27 -35.41 REMARK 500 PRO A 172 -77.70 -23.67 REMARK 500 ALA A 174 40.06 -89.91 REMARK 500 ASP A 179 23.93 -67.65 REMARK 500 ALA A 181 -158.53 -142.13 REMARK 500 ARG A 183 -72.61 -45.10 REMARK 500 ASP A 184 -37.83 -34.72 REMARK 500 MET A 190 9.41 -60.11 REMARK 500 LYS A 191 -60.47 -101.74 REMARK 500 VAL A 201 -41.99 -149.40 REMARK 500 ARG A 206 -78.63 -53.10 REMARK 500 GLU A 207 -23.73 -32.95 REMARK 500 LYS A 213 -75.22 -63.95 REMARK 500 LYS A 215 -74.75 -73.33 REMARK 500 LEU A 216 -80.72 -73.12 REMARK 500 CYS A 217 149.95 -34.39 REMARK 500 TYR A 218 -159.63 -141.62 REMARK 500 LEU A 221 -80.12 -73.03 REMARK 500 MET A 227 -64.11 -91.76 REMARK 500 SER A 235 -27.38 -39.20 REMARK 500 LEU A 242 -170.60 -54.59 REMARK 500 GLN A 246 156.56 -36.18 REMARK 500 GLU A 253 -25.87 -38.65 REMARK 500 ARG A 254 -80.06 -50.73 REMARK 500 GLU A 259 -29.10 -31.89 REMARK 500 PHE A 266 -17.46 -37.88 REMARK 500 SER A 271 162.25 -47.48 REMARK 500 ILE A 274 -81.61 -31.92 REMARK 500 HIS A 275 -35.51 -38.90 REMARK 500 ASP A 286 125.36 -38.43 REMARK 500 THR A 303 -6.78 -58.73 REMARK 500 LYS A 315 -70.63 -49.73 REMARK 500 ILE A 317 -83.09 -69.27 REMARK 500 THR A 318 -41.35 -21.13 REMARK 500 SER A 323 7.31 -60.17 REMARK 500 REMARK 500 THIS ENTRY HAS 113 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MG A 385 MG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 GLN A 137 OE1 REMARK 620 2 ATP A 380 O3G 103.8 REMARK 620 3 ATP A 380 O2B 161.4 70.5 REMARK 620 N 1 2 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MG B 785 MG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ATP B 880 O2B REMARK 620 2 ATP B 880 O1G 71.5 REMARK 620 N 1 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MG A 385 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MG B 785 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ATP A 380 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ATP B 880 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE LAR A 901 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE LAR B 921 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1ATN RELATED DB: PDB REMARK 900 RABBIT SKELETAL MUSCLE ACTIN COMPLEXED WITH DNASE I REMARK 900 RELATED ID: 1ESV RELATED DB: PDB REMARK 900 RABBIT MUSCLE ACTIN COMPLEXED WITH GELSOLIN DOMAIN 1 AND REMARK 900 LATRUNCULIN A DBREF 1IJJ A -1 375 UNP P68135 ACTS_RABIT 1 377 DBREF 1IJJ B 399 575 UNP P68135 ACTS_RABIT 1 377 SEQRES 1 A 377 MET CYS ASP GLU ASP GLU THR THR ALA LEU VAL CYS ASP SEQRES 2 A 377 ASN GLY SER GLY LEU VAL LYS ALA GLY PHE ALA GLY ASP SEQRES 3 A 377 ASP ALA PRO ARG ALA VAL PHE PRO SER ILE VAL GLY ARG SEQRES 4 A 377 PRO ARG HIS GLN GLY VAL MET VAL GLY MET GLY GLN LYS SEQRES 5 A 377 ASP SER TYR VAL GLY ASP GLU ALA GLN SER LYS ARG GLY SEQRES 6 A 377 ILE LEU THR LEU LYS TYR PRO ILE GLU HIS GLY ILE ILE SEQRES 7 A 377 THR ASN TRP ASP ASP MET GLU LYS ILE TRP HIS HIS THR SEQRES 8 A 377 PHE TYR ASN GLU LEU ARG VAL ALA PRO GLU GLU HIS PRO SEQRES 9 A 377 THR LEU LEU THR GLU ALA PRO LEU ASN PRO LYS ALA ASN SEQRES 10 A 377 ARG GLU LYS MET THR GLN ILE MET PHE GLU THR PHE ASN SEQRES 11 A 377 VAL PRO ALA MET TYR VAL ALA ILE GLN ALA VAL LEU SER SEQRES 12 A 377 LEU TYR ALA SER GLY ARG THR THR GLY ILE VAL LEU ASP SEQRES 13 A 377 SER GLY ASP GLY VAL THR HIS ASN VAL PRO ILE TYR GLU SEQRES 14 A 377 GLY TYR ALA LEU PRO HIS ALA ILE MET ARG LEU ASP LEU SEQRES 15 A 377 ALA GLY ARG ASP LEU THR ASP TYR LEU MET LYS ILE LEU SEQRES 16 A 377 THR GLU ARG GLY TYR SER PHE VAL THR THR ALA GLU ARG SEQRES 17 A 377 GLU ILE VAL ARG ASP ILE LYS GLU LYS LEU CYS TYR VAL SEQRES 18 A 377 ALA LEU ASP PHE GLU ASN GLU MET ALA THR ALA ALA SER SEQRES 19 A 377 SER SER SER LEU GLU LYS SER TYR GLU LEU PRO ASP GLY SEQRES 20 A 377 GLN VAL ILE THR ILE GLY ASN GLU ARG PHE ARG CYS PRO SEQRES 21 A 377 GLU THR LEU PHE GLN PRO SER PHE ILE GLY MET GLU SER SEQRES 22 A 377 ALA GLY ILE HIS GLU THR THR TYR ASN SER ILE MET LYS SEQRES 23 A 377 CYS ASP ILE ASP ILE ARG LYS ASP LEU TYR ALA ASN ASN SEQRES 24 A 377 VAL MET SER GLY GLY THR THR MET TYR PRO GLY ILE ALA SEQRES 25 A 377 ASP ARG MET GLN LYS GLU ILE THR ALA LEU ALA PRO SER SEQRES 26 A 377 THR MET LYS ILE LYS ILE ILE ALA PRO PRO GLU ARG LYS SEQRES 27 A 377 TYR SER VAL TRP ILE GLY GLY SER ILE LEU ALA SER LEU SEQRES 28 A 377 SER THR PHE GLN GLN MET TRP ILE THR LYS GLN GLU TYR SEQRES 29 A 377 ASP GLU ALA GLY PRO SER ILE VAL HIS ARG LYS CYS PHE SEQRES 1 B 377 MET CYS ASP GLU ASP GLU THR THR ALA LEU VAL CYS ASP SEQRES 2 B 377 ASN GLY SER GLY LEU VAL LYS ALA GLY PHE ALA GLY ASP SEQRES 3 B 377 ASP ALA PRO ARG ALA VAL PHE PRO SER ILE VAL GLY ARG SEQRES 4 B 377 PRO ARG HIS GLN GLY VAL MET VAL GLY MET GLY GLN LYS SEQRES 5 B 377 ASP SER TYR VAL GLY ASP GLU ALA GLN SER LYS ARG GLY SEQRES 6 B 377 ILE LEU THR LEU LYS TYR PRO ILE GLU HIS GLY ILE ILE SEQRES 7 B 377 THR ASN TRP ASP ASP MET GLU LYS ILE TRP HIS HIS THR SEQRES 8 B 377 PHE TYR ASN GLU LEU ARG VAL ALA PRO GLU GLU HIS PRO SEQRES 9 B 377 THR LEU LEU THR GLU ALA PRO LEU ASN PRO LYS ALA ASN SEQRES 10 B 377 ARG GLU LYS MET THR GLN ILE MET PHE GLU THR PHE ASN SEQRES 11 B 377 VAL PRO ALA MET TYR VAL ALA ILE GLN ALA VAL LEU SER SEQRES 12 B 377 LEU TYR ALA SER GLY ARG THR THR GLY ILE VAL LEU ASP SEQRES 13 B 377 SER GLY ASP GLY VAL THR HIS ASN VAL PRO ILE TYR GLU SEQRES 14 B 377 GLY TYR ALA LEU PRO HIS ALA ILE MET ARG LEU ASP LEU SEQRES 15 B 377 ALA GLY ARG ASP LEU THR ASP TYR LEU MET LYS ILE LEU SEQRES 16 B 377 THR GLU ARG GLY TYR SER PHE VAL THR THR ALA GLU ARG SEQRES 17 B 377 GLU ILE VAL ARG ASP ILE LYS GLU LYS LEU CYS TYR VAL SEQRES 18 B 377 ALA LEU ASP PHE GLU ASN GLU MET ALA THR ALA ALA SER SEQRES 19 B 377 SER SER SER LEU GLU LYS SER TYR GLU LEU PRO ASP GLY SEQRES 20 B 377 GLN VAL ILE THR ILE GLY ASN GLU ARG PHE ARG CYS PRO SEQRES 21 B 377 GLU THR LEU PHE GLN PRO SER PHE ILE GLY MET GLU SER SEQRES 22 B 377 ALA GLY ILE HIS GLU THR THR TYR ASN SER ILE MET LYS SEQRES 23 B 377 CYS ASP ILE ASP ILE ARG LYS ASP LEU TYR ALA ASN ASN SEQRES 24 B 377 VAL MET SER GLY GLY THR THR MET TYR PRO GLY ILE ALA SEQRES 25 B 377 ASP ARG MET GLN LYS GLU ILE THR ALA LEU ALA PRO SER SEQRES 26 B 377 THR MET LYS ILE LYS ILE ILE ALA PRO PRO GLU ARG LYS SEQRES 27 B 377 TYR SER VAL TRP ILE GLY GLY SER ILE LEU ALA SER LEU SEQRES 28 B 377 SER THR PHE GLN GLN MET TRP ILE THR LYS GLN GLU TYR SEQRES 29 B 377 ASP GLU ALA GLY PRO SER ILE VAL HIS ARG LYS CYS PHE HET MG A 385 1 HET ATP A 380 31 HET LAR A 901 29 HET MG B 785 1 HET ATP B 880 31 HET LAR B 921 29 HETNAM MG MAGNESIUM ION HETNAM ATP ADENOSINE-5'-TRIPHOSPHATE HETNAM LAR LATRUNCULIN A HETSYN LAR 4-(17-HYDROXY-5,12-DIMETHYL-3-OXO-2,16- HETSYN 2 LAR DIOXABICYCLO[13.3.1]NONADECA-4,8,10-TRIEN-17-YL)-2- HETSYN 3 LAR THIAZOLIDINONE FORMUL 3 MG 2(MG 2+) FORMUL 4 ATP 2(C10 H16 N5 O13 P3) FORMUL 5 LAR 2(C22 H31 N O5 S) FORMUL 9 HOH *56(H2 O) HELIX 1 1 VAL A 54 LYS A 61 1 8 HELIX 2 2 ARG A 62 LEU A 65 5 4 HELIX 3 3 ASN A 78 LEU A 94 1 17 HELIX 4 4 ALA A 97 HIS A 101 5 5 HELIX 5 5 PRO A 112 ASN A 128 1 17 HELIX 6 6 GLN A 137 ALA A 144 1 8 HELIX 7 7 LEU A 171 ILE A 175 5 5 HELIX 8 8 ALA A 181 LEU A 193 1 13 HELIX 9 9 THR A 202 LEU A 216 1 15 HELIX 10 10 ASN A 252 CYS A 257 1 6 HELIX 11 11 PRO A 258 PHE A 262 5 5 HELIX 12 12 GLN A 263 GLY A 268 5 6 HELIX 13 13 GLY A 273 LYS A 284 1 12 HELIX 14 14 ASP A 286 ASN A 296 1 11 HELIX 15 15 GLY A 301 TYR A 306 5 6 HELIX 16 16 GLY A 308 ALA A 319 1 12 HELIX 17 17 PRO A 332 LYS A 336 5 5 HELIX 18 18 TYR A 337 SER A 348 1 12 HELIX 19 19 LEU A 349 MET A 355 5 7 HELIX 20 20 LYS A 359 ALA A 365 1 7 HELIX 21 21 GLY A 366 ARG A 372 5 7 HELIX 22 22 LYS B 461 GLY B 463 5 3 HELIX 23 23 ASN B 478 GLU B 493 1 16 HELIX 24 24 ALA B 497 HIS B 501 5 5 HELIX 25 25 PRO B 512 ASN B 528 1 17 HELIX 26 26 GLN B 537 ALA B 544 1 8 HELIX 27 27 LEU B 571 ILE B 575 5 5 HELIX 28 28 ALA B 581 LEU B 593 1 13 HELIX 29 29 THR B 602 LEU B 616 1 15 HELIX 30 30 PHE B 623 ALA B 628 1 6 HELIX 31 31 PHE B 655 THR B 660 1 6 HELIX 32 32 LEU B 661 PHE B 662 5 2 HELIX 33 33 GLN B 663 GLY B 668 5 6 HELIX 34 34 GLY B 673 CYS B 685 1 13 HELIX 35 35 ASP B 686 ASP B 688 5 3 HELIX 36 36 ILE B 689 ASN B 696 1 8 HELIX 37 37 GLY B 701 MET B 705 5 5 HELIX 38 38 GLY B 708 ALA B 719 1 12 HELIX 39 39 GLU B 734 LYS B 736 5 3 HELIX 40 40 TYR B 737 SER B 748 1 12 HELIX 41 41 LEU B 749 MET B 755 5 7 HELIX 42 42 LYS B 759 ALA B 765 1 7 HELIX 43 43 GLY B 766 HIS B 771 5 6 SHEET 1 A 6 ALA A 29 PRO A 32 0 SHEET 2 A 6 LEU A 16 ALA A 19 -1 N VAL A 17 O PHE A 31 SHEET 3 A 6 LEU A 8 ASN A 12 -1 N ASP A 11 O LYS A 18 SHEET 4 A 6 THR A 103 GLU A 107 1 O LEU A 104 N LEU A 8 SHEET 5 A 6 ALA A 131 ILE A 136 1 O TYR A 133 N LEU A 105 SHEET 6 A 6 ILE A 357 THR A 358 -1 O ILE A 357 N MET A 132 SHEET 1 B 2 VAL A 35 ARG A 37 0 SHEET 2 B 2 THR A 66 LYS A 68 -1 O LYS A 68 N VAL A 35 SHEET 1 C 2 ILE A 71 GLU A 72 0 SHEET 2 C 2 ILE A 75 ILE A 76 -1 O ILE A 75 N GLU A 72 SHEET 1 D 5 MET A 176 LEU A 178 0 SHEET 2 D 5 THR A 160 ILE A 165 -1 N THR A 160 O LEU A 178 SHEET 3 D 5 GLY A 150 SER A 155 -1 N GLY A 150 O ILE A 165 SHEET 4 D 5 ASN A 297 SER A 300 1 O SER A 300 N LEU A 153 SHEET 5 D 5 ILE A 329 ILE A 330 1 O ILE A 330 N MET A 299 SHEET 1 E 2 LYS A 238 SER A 239 0 SHEET 2 E 2 THR A 249 ILE A 250 -1 O ILE A 250 N LYS A 238 SHEET 1 F 6 ALA B 429 PRO B 432 0 SHEET 2 F 6 LEU B 416 PHE B 421 -1 N VAL B 417 O PHE B 431 SHEET 3 F 6 LEU B 408 ASN B 412 -1 N ASP B 411 O LYS B 418 SHEET 4 F 6 THR B 503 GLU B 507 1 O LEU B 504 N LEU B 408 SHEET 5 F 6 ALA B 531 ILE B 536 1 O ALA B 531 N THR B 503 SHEET 6 F 6 ILE B 757 THR B 758 -1 O ILE B 757 N MET B 532 SHEET 1 G 2 VAL B 435 PRO B 438 0 SHEET 2 G 2 LEU B 465 LYS B 468 -1 O THR B 466 N ARG B 437 SHEET 1 H 2 ILE B 471 GLU B 472 0 SHEET 2 H 2 ILE B 475 ILE B 476 -1 O ILE B 475 N GLU B 472 SHEET 1 I 5 MET B 576 LEU B 578 0 SHEET 2 I 5 THR B 560 ILE B 565 -1 N ASN B 562 O MET B 576 SHEET 3 I 5 GLY B 550 SER B 555 -1 N GLY B 550 O ILE B 565 SHEET 4 I 5 ASN B 697 SER B 700 1 O VAL B 698 N LEU B 553 SHEET 5 I 5 ILE B 729 ILE B 730 1 O ILE B 730 N MET B 699 LINK OE1 GLN A 137 MG MG A 385 1555 1555 2.81 LINK O3G ATP A 380 MG MG A 385 1555 1555 2.41 LINK O2B ATP A 380 MG MG A 385 1555 1555 2.46 LINK MG MG B 785 O2B ATP B 880 1555 1555 2.22 LINK MG MG B 785 O1G ATP B 880 1555 1555 2.63 SITE 1 AC1 2 GLN A 137 ATP A 380 SITE 1 AC2 2 GLN B 537 ATP B 880 SITE 1 AC3 19 GLY A 13 SER A 14 GLY A 15 LEU A 16 SITE 2 AC3 19 LYS A 18 GLY A 156 ASP A 157 GLY A 158 SITE 3 AC3 19 VAL A 159 GLY A 182 LYS A 213 GLU A 214 SITE 4 AC3 19 GLY A 301 GLY A 302 THR A 303 MET A 305 SITE 5 AC3 19 TYR A 306 MG A 385 LAR A 901 SITE 1 AC4 18 GLY B 413 SER B 414 GLY B 415 LEU B 416 SITE 2 AC4 18 LYS B 418 GLY B 556 ASP B 557 GLY B 558 SITE 3 AC4 18 VAL B 559 GLY B 582 GLU B 614 GLY B 701 SITE 4 AC4 18 GLY B 702 THR B 703 MET B 705 TYR B 706 SITE 5 AC4 18 MG B 785 LAR B 921 SITE 1 AC5 12 GLY A 15 PRO A 32 ILE A 34 TYR A 69 SITE 2 AC5 12 ASP A 157 ARG A 183 THR A 186 ARG A 206 SITE 3 AC5 12 GLU A 207 ARG A 210 GLU A 214 ATP A 380 SITE 1 AC6 13 GLY B 415 LEU B 416 PRO B 432 ILE B 434 SITE 2 AC6 13 GLN B 459 TYR B 469 ASP B 557 ARG B 583 SITE 3 AC6 13 THR B 586 ARG B 606 GLU B 607 ARG B 610 SITE 4 AC6 13 ATP B 880 CRYST1 100.304 102.183 124.218 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.009970 0.000000 0.000000 0.00000 SCALE2 0.000000 0.009786 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008050 0.00000